SAN DIEGO, Jan. 29 /PRNewswire/ -- ChemDiv, Inc., a leading chemistry-driven global contract research organization, has announced today that it has entered into a discovery collaboration with Achaogen, Inc., South San Francisco, CA. Applying its expertise in medicinal and synthetic chemistry, ChemDiv will support Achaogen in identifying and developing novel antibacterial compounds. Financial terms of the collaboration were not disclosed.
“We look forward to collaborating with Achaogen on this exciting project where ChemDiv’s strong medicinal chemistry expertise and integrated drug discovery capabilities will provide our partner with the tools for successful research operations and help them achieve rapid progress in this area,” said Alex Khvat, Sr. Director of Chemistry at ChemDiv, Inc.
“We are pleased to be working with ChemDiv on this important medicinal chemistry effort to optimize SOS pathway inhibitors discovered by Achaogen,” said Dr. Heinz Moser, Achaogen’s Senior Vice President for Chemistry. “These inhibitors could prove to be powerful new tools in the battle against antimicrobial resistance.”
About ChemDiv, Inc.:
ChemDiv, Inc. (Chemical Diversity) is a global chemistry-driven contract research organization delivering discovery opportunities and services for life science partners. ChemDiv is merging industrial and academic efforts to bring new approaches to the treatment of life-threatening diseases. http://www.chemdiv.com
About Achaogen, Inc.:
Achaogen (a-KAY-oh-jen) is addressing the widespread emergence of bacterial resistance through the discovery and development of small molecule anti-infectives. Achaogen focuses on both known classes of antibiotics, as well as wholly novel classes of new drugs that will act through validated but as yet unexploited bacterial targets. For more information about Achaogen please contact John Hollway, Vice President, Business Development at 650-266-1120 or bd@achaogen.com, or visit http://www.achaogen.com.
CONTACT: Ronald Demuth, General Manager of ChemDiv, Inc., +1-858-794-4860,
fax, +1-858-794-4931, rdemuth@chemdiv.com; or John Hollway, Vice President,
Business Development of Achaogen, Inc., +1-650-266-1120, bd@achaogen.com
Web site: http://www.chemdiv.com/
http://www.achaogen.com/
